Mabwell Receives NMPA Approval for Clinical Trial of Novel Nectin-4 Targeting ADC in TNBC The study includes two cohorts: Cohort A will enroll patients [...] By digitalstudios|2024-07-15T14:45:42+00:00July 15, 2024|3rd Party Medical Device Industry News|Comments Off on Mabwell Receives NMPA Approval for Clinical Trial of Novel Nectin-4 Targeting ADC in TNBC Read More
